A lack of universally accepted classification criteria for patients with juvenile spondyloarthritis (SpA) has hindered efforts to develop tools to assess the severity and progression of this disease. With the publication of a new juvenile SpA disease activity index, has this gap now been bridged, and is it a comprehensive tool for the clinic?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Weiss, P. F. et al. Development and retrospective validation of the juvenile spondyloarthritis disease activity (JSpADA) index. Arthritis Care Res. (Hoboken) http://dx.doi.org/10.1002/acr.22411.
Petty, R. E. et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J. Rheumatol. 31, 390–392 (2004).
Beukelman, T. et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res. (Hoboken) 63, 465–482 (2011).
Wallace, C. A. et al. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res. (Hoboken) 63, 929–936 (2011).
Horneff, G. et al. Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study. Ann. Rheum. Dis. 73, 1114–1122 (2013).
Rachlis, A. C. et al. Validation of BASDAI and BASFI in children with spondyloarthritis [abstract 24]. Arthritis Rheum. 66 (Suppl. 11), S38 (2014).
Batthish, M. et al. Intra-rater reliability of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Bath Ankylosing Spondylitis Functional Index (BASFI) in children with spondyloarthritis [abstract]. Arthritis Rheum. 62 (Suppl. 10), S225 (2010).
Stoll, M. L., Bhore, R., Dempsey-Robertson, M. & Punaro, M. Spondyloarthritis in a pediatric population: risk factors for sacroiliitis. J. Rheumatol. 37, 2402–2408 (2010).
Filocamo, G. et al. A new approach to clinical care of juvenile idiopathic arthritis: the Juvenile Arthritis Multidimensional Assessment Report. J. Rheumatol. 38, 938–953 (2011).
Weiss, P. F., Beukelman, T., Schanberg, L. E., Kimura, Y. & Colbert, R. A. Enthesitis-related arthritis is associated with higher pain intensity and poorer health status in comparison with other categories of juvenile idiopathic arthritis: the Childhood Arthritis and Rheumatology Research Alliance Registry. J. Rheumatol. 39, 2341–2351 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Berard, R., Laxer, R. A disease activity index for juvenile SpA—a welcome addition. Nat Rev Rheumatol 10, 642–644 (2014). https://doi.org/10.1038/nrrheum.2014.150
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2014.150